Compare Arbitrum (ARB) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Arbitrum vs Mira — how do they compare? Arbitrum trades at Rp1,334 (market cap Rp8,84T, Rp592,42M 24h volume), while Mira trades at Rp700.16 (market cap Rp226,43M, Rp101,47M 24h volume). The key difference: Arbitrum is far larger — about 39040.8× Mira's market cap, and Mira's supply is capped (321,5M / 1B MIRA (33%)) while Arbitrum's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Arbitrum for 63 Days and Mira for 22 Days on average.
| ARB | MIRA | |
|---|---|---|
Market Cap | Rp8,84T | Rp226,43M |
Volume (24h) | Rp592,42M | Rp101,47M |
Circulating Supply | 6,6B ARB | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 63 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Arbitrum (ARB) is currently trading at Rp1,334 with a bearish technical outlook, showing strong selling pressure across moving averages while oscillators remain neutral. The token faces resistance at Rp1,370 and finds support at Rp1,321, with recent ecosystem news highlighting Pheasant Network's $2M funding round to advance AI-powered cross-chain technology. Market cap stands at Rp8.84 trillion with 6.6 million tokens in circulation.
Overall outlook remains cautious due to bearish technical signals, though neutral RSI levels suggest potential stabilization. Key opportunities include ecosystem growth from AI integration projects, while major risks involve continued selling pressure and crypto market volatility. Investors should monitor support levels closely.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Arbitrum
Arbitrum is an Ethereum layer-2 scaling solution. It uses optimistic rollups to achieve its goal of improving speed, scalability and cost-efficiency on Ethereum. Arbitrum benefits from the security and compatibility of Ethereum. Another benefit is the higher throughput and lower fees compared to Ethereum. That is made possible thanks to moving most of the computation and storage load off-chain. Arbitrum’s native token is called ARB and is used for governance. Offchain Labs, the developers behind Arbitrum, announced the shift to a decentralized autonomous organization (DAO) structure — the Arbitrum DAO. ARB holders can vote on proposals that affect the features, protocol upgrades, funds allocation and election of a Security Council.
Read more on ARB →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
